Investigation of the therapeutic effectiveness of active components in Sini decoction by a comprehensive GC/LC-MS based metabolomics and network pharmacology approaches.

As a classical formula, Sini decoction (SND) has been fully proved to be clinically effective in treating doxorubicin (DOX)-induced cardiomyopathy. Current chemomics and pharmacology proved that the total alkaloids (TA), total gingerols (TG), total flavones and total saponins (TFS) are the major active ingredients of Aconitum carmichaelii, Zingiber officinale and Glycyrrhiza uralensis in SND respectively. Our animal experiments in this study demonstrated that the above active ingredients (TAGFS) were more effective than formulas formed by any one or two of the three individual components and nearly the same as SND. However, very little is known about the action mechanisms of TAGFS. Thus, this study aimed to use for the first time the combination of GC/LC-MS based metabolomics and network pharmacology for solving this problem. By metabolomics, it was found that TAGFS worked by regulating six primary pathways. Then, network pharmacology was applied to search for specific targets. 17 potential cardiovascular related targets were found through molecular docking, 11 of which were identified by references, which demonstrated the therapeutic effectiveness of TAGFS using network pharmacology. Among these targets, four targets, including phosphoinositide 3-kinase gamma, insulin receptor, ornithine aminotransferase and glucokinase, were involved in the TAGFS regulated pathways. Moreover, phosphoinositide 3-kinase gamma, insulin receptor and glucokinase were proved to be targets of active components in SND. In addition, our data indicated TA as the principal ingredient in the SND formula, whereas TG and TFS served as adjuvant ingredients. We therefore suggest that dissecting the mode of action of clinically effective formulae with the combination use of metabolomics and network pharmacology may be a good strategy.

[1]  Feng-peng Wang,et al.  Structure-Cardiac Activity Relationship of C19-Diterpenoid Alkaloids , 2012, Natural Product Communications.

[2]  A. Bordoni,et al.  Doxorubicin induces early lipid peroxidation associated with changes in glucose transport in cultured cardiomyocytes. , 2002, Biochimica et biophysica acta.

[3]  Z. Lou,et al.  Potential Biomarkers in Mouse Myocardium of Doxorubicin-Induced Cardiomyopathy: A Metabonomic Method and Its Application , 2011, PloS one.

[4]  P. Shannon,et al.  Cytoscape: a software environment for integrated models of biomolecular interaction networks. , 2003, Genome research.

[5]  M. Chance,et al.  Molecular Targets for Diabetes Mellitus-associated Erectile Dysfunction* , 2009, Molecular & Cellular Proteomics.

[6]  Fengzhi Li,et al.  Exploring long-term protection of normal human fibroblasts and epithelial cells from chemotherapy in cell culture , 2011, Oncotarget.

[7]  Zhi-xiang Shen,et al.  Dissection of mechanisms of Chinese medicinal formula Realgar-Indigo naturalis as an effective treatment for promyelocytic leukemia , 2008, Proceedings of the National Academy of Sciences.

[8]  Chuang Liu,et al.  Prediction of Drug-Target Interactions and Drug Repositioning via Network-Based Inference , 2012, PLoS Comput. Biol..

[9]  J. Drews.  Drug discovery: a historical perspective. , 2000, Science.

[10]  Wei-Kang Wu,et al.  Higenamine Combined with [6]-Gingerol Suppresses Doxorubicin-Triggered Oxidative Stress and Apoptosis in Cardiomyocytes via Upregulation of PI3K/Akt Pathway , 2013, Evidence-based complementary and alternative medicine : eCAM.

[11]  Hung-Yi Wu,et al.  Molecular Mechanisms of Doxorubicin-induced Cardiomyopathy , 1997, The Journal of Biological Chemistry.

[12]  J. Duan,et al.  Metabolism-based synthesis, biologic evaluation and SARs analysis of O-methylated analogs of quercetin as thrombin inhibitors. , 2012, European journal of medicinal chemistry.

[13]  Z. Lou,et al.  Characterization of constituents in Sini decoction and rat plasma by high-performance liquid chromatography with diode array detection coupled to time-of-flight mass spectrometry. , 2011, Biomedical chromatography : BMC.

[14]  W. Marsden.  I and J , 2012 .

[15]  V. Klimberg,et al.  Oral glutamine protects against acute doxorubicin-induced cardiotoxicity of tumor-bearing rats. , 2010, The Journal of nutrition.

[16]  Jie Li,et al.  Prediction of Polypharmacological Profiles of Drugs by the Integration of Chemical, Side Effect, and Therapeutic Space , 2013, J. Chem. Inf. Model..

[17]  A. Bordoni,et al.  The impairment of essential fatty acid metabolism as a key factor in doxorubicin-induced damage in cultured rat cardiomyocytes. , 1999, Biochimica et biophysica acta.

[18]  G. G. Stokes.  "J." , 1890, The New Yale Book of Quotations.

[19]  R. Verpoorte,et al.  Ethnopharmacology and systems biology: a perfect holistic match. , 2005, Journal of ethnopharmacology.

[20]  Peng Jiang,et al.  Molecular networks for the study of TCM Pharmacology , 2010, Briefings Bioinform..

[21]  D. Aggarwal,et al.  Analysis of proteome changes in doxorubicin-treated adult rat cardiomyocyte. , 2011, Journal of proteomics.

[22]  R. Tagliaferri,et al.  Discovery of drug mode of action and drug repositioning from transcriptional responses , 2010, Proceedings of the National Academy of Sciences.

[23]  Na Li,et al.  Network pharmacology study on the mechanism of traditional Chinese medicine for upper respiratory tract infection. , 2014, Molecular bioSystems.

[24]  Jing Zhao,et al.  Therapeutic Effects of Astragaloside IV on Myocardial Injuries: Multi-Target Identification and Network Analysis , 2012, PloS one.

[25]  Shao Li,et al.  A novel network pharmacology approach to analyse traditional herbal formulae: the Liu-Wei-Di-Huang pill as a case study. , 2014, Molecular bioSystems.

[26]  Yadi Zhou,et al.  Prediction of chemical-protein interactions: multitarget-QSAR versus computational chemogenomic methods. , 2012, Molecular bioSystems.

[27]  Z. Lou,et al.  Analysis of phenolic and triterpenoid compounds in licorice and rat plasma by high-performance liquid chromatography diode-array detection, time-of-flight mass spectrometry and quadrupole ion trap mass spectrometry. , 2010, Rapid communications in mass spectrometry : RCM.

[28]  E. Want,et al.  Global metabolic profiling procedures for urine using UPLC–MS , 2010, Nature Protocols.

[29]  Michael J. Keiser,et al.  Large Scale Prediction and Testing of Drug Activity on Side-Effect Targets , 2012, Nature.

[30]  J. Lindon,et al.  'Metabonomics': understanding the metabolic responses of living systems to pathophysiological stimuli via multivariate statistical analysis of biological NMR spectroscopic data. , 1999, Xenobiotica; the fate of foreign compounds in biological systems.

[31]  V. Sathish,et al.  Adriamycin induced myocardial failure in rats: Protective role of Centella asiatica , 2006, Molecular and Cellular Biochemistry.

[32]  P. Cohen,et al.  Specificity and mechanism of action of some commonly used protein kinase inhibitors , 2000 .

[33]  Yu Cao,et al.  Metabonomic evaluation of melamine-induced acute renal toxicity in rats. , 2010, Journal of proteome research.

[34]  Min Ye,et al.  Chemical analysis of the Chinese herbal medicine Gan-Cao (licorice). , 2009, Journal of chromatography. A.

[35]  M. Wymann,et al.  Inhibition of phosphoinositide 3‐kinase γ attenuates inflammation, obesity, and cardiovascular risk factors , 2013, Annals of the New York Academy of Sciences.

[36]  T. Kálai,et al.  Regulation of Kinase Cascade Activation and Heat Shock Protein Expression by Poly(ADP-ribose) Polymerase Inhibition in Doxorubicin-induced Heart Failure , 2011, Journal of cardiovascular pharmacology.

[37]  N. Sarvazyan,et al.  Changes in Phospholipid Content and Myocardial Calcium-Independent Phospholipase A2 Activity during Chronic Anthracycline Administration , 2004, Journal of Pharmacology and Experimental Therapeutics.

[38]  Xue Xu,et al.  Network pharmacology-based prediction of the active ingredients and potential targets of Chinese herbal Radix Curcumae formula for application to cardiovascular disease. , 2013, Journal of ethnopharmacology.

[39]  F. Song,et al.  Studies on the aconitine-type alkaloids in the roots of Aconitum Carmichaeli Debx. by HPLC/ESIMS/MS(n). , 2009, Talanta.

[40]  A. Fischman,et al.  Myocardial substrate utilization and left ventricular function in adriamycin cardiomyopathy. , 1993, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[41]  E. Hirsch,et al.  Phosphoinositide 3-kinase γ : kinase-dependent and -independent activities in cardiovascular function and disease , 2004 .

[42]  T. Wallimann,et al.  Alterations in myocardial energy metabolism induced by the anti-cancer drug doxorubicin. , 2006, Comptes rendus biologies.

[43]  Z. Lou,et al.  Screening and analysis of aconitum alkaloids and their metabolites in rat urine after oral administration of aconite roots extract using LC-TOFMS-based metabolomics. , 2011, Biomedical chromatography : BMC.

[44]  K. Jacobson,et al.  Activation of A3Adenosine Receptor Protects Against Doxorubicin-induced Cardiotoxicity ☆ , 2001 .

[45]  Z. Lou,et al.  Metabolic Profiling Provides a System Understanding of Hypothyroidism in Rats and Its Application , 2013, PloS one.

[46]  Dinender K Singla,et al.  Notch-1 Mediated Cardiac Protection following Embryonic and Induced Pluripotent Stem Cell Transplantation in Doxorubicin-Induced Heart Failure , 2014, PloS one.

[47]  J. Chen,et al.  Metabonomics study of liver cancer based on ultra performance liquid chromatography coupled to mass spectrometry with HILIC and RPLC separations. , 2009, Analytica chimica acta.

[48]  Lin He,et al.  DRAR-CPI: a server for identifying drug repositioning potential and adverse drug reactions via the chemical–protein interactome , 2011, Nucleic Acids Res..

[49]  J. Bauer,et al.  Intracellular distribution of peroxynitrite during doxorubicin cardiomyopathy: evidence for selective impairment of myofibrillar creatine kinase , 2002, British journal of pharmacology.

[50]  Miss A.O. Penney.  (b) , 1974, The New Yale Book of Quotations.

[51]  L. Ahmed,et al.  Nicorandil ameliorates mitochondrial dysfunction in doxorubicin-induced heart failure in rats: possible mechanism of cardioprotection. , 2013, Biochemical pharmacology.

[52]  L. Michalis,et al.  Hsp70 regulates the doxorubicin-mediated heart failure in Hsp70-transgenic mice , 2014, Cell Stress and Chaperones.

[53]  R. Witkamp,et al.  Metabolomics in the context of systems biology: bridging traditional Chinese medicine and molecular pharmacology , 2005, Phytotherapy research : PTR.

[54]  N. Sarvazyan,et al.  Inhibition of membrane-associated calcium-independent phospholipase A2 as a potential culprit of anthracycline cardiotoxicity. , 2003, Cancer research.

[55]  M. Seishima,et al.  EFFECTS OF ADRENALINE INFUSION ON PLASMA LIPIDS AND NORADRENALINE LEVELS IN RABBITS WITH ADRIAMYCIN‐INDUCED CARDIOMYOPATHY , 1997, Clinical and experimental pharmacology & physiology.

[56]  R. Bauer,et al.  A novel concept for detoxification: complexation between aconitine and liquiritin in a Chinese herbal formula ('Sini Tang'). , 2013, Journal of ethnopharmacology.

[57]  Charles Auffray,et al.  Systems analysis of transcriptome and proteome in retinoic acid/arsenic trioxide-induced cell differentiation/apoptosis of promyelocytic leukemia. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[58]  Lee Jia Ming,et al.  Therapeutic Effects of Glycyrrhizic Acid , 2013, Natural product communications.

[59]  G. Lopaschuk,et al.  Metabolic remodeling associated with subchronic doxorubicin cardiomyopathy. , 2010, Toxicology.

[60]  Aaas News,et al.  Book Reviews , 1893, Buffalo Medical and Surgical Journal.

[61]  S. Eksborg,et al.  Doxorubicin- and daunorubicin-induced energy deprivation and nucleotide degradation in isolated cardiomyocytes. , 1996, Toxicology.

[62]  Wei Zhu,et al.  Computational network pharmacological research of Chinese medicinal plants for chronic kidney disease , 2010 .

[63]  R. Stephenson.  A and V , 1962, The British journal of ophthalmology.